Craig Hallum Analysts Give Proto Labs (PRLB) a $92.00 Price Target
Several other research firms have also commented on PRLB. Zacks Investment Research raised shares of Proto Labs from a hold rating to a buy rating and set a $96.00 price target for the company in a research report on Friday, November 3rd. BidaskClub lowered shares of Proto Labs from a strong-buy rating to a buy rating in a research report on Friday, October 6th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Proto Labs presently has an average rating of Hold and a consensus price target of $75.00.
Proto Labs (PRLB) opened at $95.95 on Monday. Proto Labs has a 1-year low of $48.00 and a 1-year high of $96.55. The stock has a market cap of $2,542.01, a PE ratio of 54.51, a price-to-earnings-growth ratio of 2.39 and a beta of 1.03.
Proto Labs (NYSE:PRLB) last issued its earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The company had revenue of $88.10 million for the quarter, compared to analysts’ expectations of $85.68 million. Proto Labs had a net margin of 14.53% and a return on equity of 11.63%. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.51 EPS. equities analysts expect that Proto Labs will post 1.9 EPS for the current year.
In related news, Director Rainer Gawlick sold 1,500 shares of the stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $90.31, for a total value of $135,465.00. Following the completion of the transaction, the director now directly owns 6,925 shares of the company’s stock, valued at approximately $625,396.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP John B. Tumelty sold 13,556 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $92.07, for a total transaction of $1,248,100.92. The disclosure for this sale can be found here. Corporate insiders own 7.78% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Victory Capital Management Inc. raised its position in shares of Proto Labs by 17.7% in the 2nd quarter. Victory Capital Management Inc. now owns 2,323 shares of the industrial products company’s stock valued at $156,000 after purchasing an additional 349 shares during the last quarter. UBS Group AG raised its position in shares of Proto Labs by 128.0% in the 1st quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock valued at $133,000 after purchasing an additional 11,895 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new position in shares of Proto Labs in the 3rd quarter valued at approximately $238,000. Hanseatic Management Services Inc. purchased a new position in shares of Proto Labs in the 3rd quarter valued at approximately $243,000. Finally, BB&T Corp purchased a new position in shares of Proto Labs in the 2nd quarter valued at approximately $205,000.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.